美国肾脏病学会关于负责任使用人工智能改善肾脏照护的声明
美国肾脏病学会召集AI工作组,提出在肾脏病学中负责任使用AI的框架,强调以患者获益为核心、保持临床医生监督,并概述AI在CKD、AKI、透析和移植中的临床应用及数据质量、公平性、透明度和临床整合等挑战。
要点
- AI应用应以患者获益为核心,并确保临床医生始终参与决策。
- 声明为肾脏病医生在CKD、AKI、透析和移植中整合AI提供实践指导。
- 需应对数据质量、公平性、透明度和临床整合等关键挑战。
核心结论
- AI可改善肾脏照护,但须以患者获益、临床医生监督和解决高负担疾病领域创新为基本原则负责任地使用。
研究设计与样本
- 美国肾脏病学会召集AI工作组制定的声明,基于医生始终参与和以肾病患者获益为总体目标的假设。
主要发现
- AI通过预测分析、机器学习、深度学习和生成式AI技术正在迅速改变肾脏照护的提供方式。
- 声明概述了AI在肾脏病学中的临床应用,并提供了在CKD、AKI、透析和移植管理中整合AI的实践指导。
- 数据质量、公平性、透明度和临床整合是确保AI负责任有效实施必须解决的关键挑战。
关键数值与推荐
- 基本原则包括优先考虑患者获益、确保临床医生监督和推进高负担疾病领域的创新。
临床怎么用
- 肾脏病医生可参考该声明在CKD、AKI、透析和移植照护中负责任地纳入AI工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Artificial intelligence (AI) is rapidly transforming the delivery of kidney care through predictive analytics, machine learning, deep learning, and generative AI technologies. To meet this challenge, the American Society of Nephrology convened an AI Workgroup to provide a framework for the responsible use of AI in nephrology. The group outlines foundational principles to guide AI development: prioritizing patient benefit, ensuring clinician oversight, and advancing innovation in high-burden disease areas. Its set of foundational assumptions are grounded in the physician always being in the loop and an overarching goal to benefit patients with kidney diseases. This review provides an overview of the clinical uses of AI in nephrology and offers practical guidance for nephrologists seeking to incorporate AI into CKD and AKI management, dialysis, and transplantation care. It also highlights key challenges-such as data quality, equity, transparency, and clinical integration-that must be addressed to ensure the responsible and effective implementation of AI in kidney care.
引用
- Tangri N, Cheungpasitporn W, Crittenden SD, et al. Responsible Use of Artificial Intelligence to Improve Kidney Care: A Statement from the American Society of Nephrology. J Am Soc Nephrol. 2025. PMID: 41201255. doi:10.1681/ASN.0000000929
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。